Bryan A Lieber1, James Han2, Geoffrey Appelboom3, Blake E S Taylor4, ByoungJun Han5, Nitin Agarwal6, E Sander Connolly7. 1. Cerebrovascular Laboratory, Columbia University, New York, New York, USA; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; School of Medicine, New York University, New York, New York, USA. Electronic address: Elisha.lieber@gmail.com. 2. Weill Cornell Medical College, Cornell University, New York, New York, USA. 3. Cerebrovascular Laboratory, Columbia University, New York, New York, USA. 4. Cerebrovascular Laboratory, Columbia University, New York, New York, USA; College of Physicians and Surgeons, Columbia University, New York, New York, USA; Department of Neurosurgery, Columbia University, New York, New York, USA. 5. School of Medicine, New York University, New York, New York, USA. 6. Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. 7. Cerebrovascular Laboratory, Columbia University, New York, New York, USA; Department of Neurosurgery, Columbia University, New York, New York, USA; Neuro-Intensive Care Unit, Columbia University Medical Center, New York, New York, USA.
Abstract
OBJECTIVE: Venous thromboembolism (VTE) is a major preventable cause of morbidity and mortality in hospitalized patients and is a widely accepted measure for quality of care. Prolonged corticosteroid therapy, which is common in neurosurgical patients, has been associated with VTE. Using a national database, we sought to determine whether corticosteroid use for >10 days was an independent risk factor for deep venous thrombosis (DVT) and pulmonary embolism (PE). METHODS: The well-validated American College of Surgeons National Surgical Quality Improvement Program database was queried to evaluate the rates of VTE during the period 2006-2013 in patients undergoing neurosurgical procedures. A multivariate regression model was constructed to assess the effect of prolonged corticosteroid use on the occurrence of PE and DVT by postoperative day 30. RESULTS: Of 94,620 patients identified, 565 (0.60%) developed PE and 1057 (1.12%) developed DVT within 30 days after surgery. In the multivariate model, patients receiving corticosteroids were significantly more likely to have PE (odds ratio = 1.47, 95% confidence interval = 1.13-1.90, P = 0.004) and DVT (odds ratio = 1.55, 95% confidence interval = 1.28-1.87, P < 0.001). Other factors independently associated with development of PE and DVT included the presence of malignancy, longer hospitalization, certain infections (including pneumonia and urinary tract infections), and stroke with a neurologic deficit. CONCLUSIONS: In the neurosurgical population, prolonged courses of corticosteroids are associated with an increased risk of developing postoperative DVT and PE, even when controlling for potential confounders.
OBJECTIVE:Venous thromboembolism (VTE) is a major preventable cause of morbidity and mortality in hospitalized patients and is a widely accepted measure for quality of care. Prolonged corticosteroid therapy, which is common in neurosurgical patients, has been associated with VTE. Using a national database, we sought to determine whether corticosteroid use for >10 days was an independent risk factor for deep venous thrombosis (DVT) and pulmonary embolism (PE). METHODS: The well-validated American College of Surgeons National Surgical Quality Improvement Program database was queried to evaluate the rates of VTE during the period 2006-2013 in patients undergoing neurosurgical procedures. A multivariate regression model was constructed to assess the effect of prolonged corticosteroid use on the occurrence of PE and DVT by postoperative day 30. RESULTS: Of 94,620 patients identified, 565 (0.60%) developed PE and 1057 (1.12%) developed DVT within 30 days after surgery. In the multivariate model, patients receiving corticosteroids were significantly more likely to have PE (odds ratio = 1.47, 95% confidence interval = 1.13-1.90, P = 0.004) and DVT (odds ratio = 1.55, 95% confidence interval = 1.28-1.87, P < 0.001). Other factors independently associated with development of PE and DVT included the presence of malignancy, longer hospitalization, certain infections (including pneumonia and urinary tract infections), and stroke with a neurologic deficit. CONCLUSIONS: In the neurosurgical population, prolonged courses of corticosteroids are associated with an increased risk of developing postoperative DVT and PE, even when controlling for potential confounders.
Authors: Ian A Buchanan; Michelle Lin; Daniel A Donoho; Arati Patel; Li Ding; Arun P Amar; Steven L Giannotta; William J Mack; Frank Attenello Journal: World Neurosurg Date: 2018-11-20 Impact factor: 2.104
Authors: David J Cote; Hormuzdiyar H Dasenbrock; William B Gormley; Timothy R Smith; Ian F Dunn Journal: World Neurosurg Date: 2019-05-11 Impact factor: 2.104
Authors: Hassan Aziz; Ye In Christopher Kwon; Saba Alvi; Shahzaib Ahmad; Sangrag Ganguli; Martin Goodman; Yong K Kwon Journal: J Gastrointest Surg Date: 2022-07-01 Impact factor: 3.267
Authors: Frank R Chen; Theodore Quan; Joseph E Manzi; Alex Gu; Chapman Wei; Sean Tabaie; Marc Chodos; Cary B Chapman; Kane O Pryor; Jiabin Liu Journal: Iowa Orthop J Date: 2022-06
Authors: Joeky T Senders; Nicole H Goldhaber; David J Cote; Ivo S Muskens; Hassan Y Dawood; Filip Y F L De Vos; William B Gormley; Timothy R Smith; Marike L D Broekman Journal: J Neurooncol Date: 2017-10-16 Impact factor: 4.130
Authors: Mackenzie Ruehl; Alex M Lynch; Therese E O'Toole; Bari Morris; John Rush; C Guillermo Couto; Samantha Hmelo; Stacey Sonnenshein; Amy Butler; Julien Guillaumin Journal: J Vet Intern Med Date: 2020-08-15 Impact factor: 3.333
Authors: Ronaldo C Go; Themba Nyirenda; Maryam Bojarian; Davood K Hosseini; Mehek Rahim; Kevin Kim; Keith M Rose Journal: BMC Pulm Med Date: 2022-01-06 Impact factor: 3.317